<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid Antibody</z:hpo> Syndrome (APS) is defined by arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, recurrent <z:hpo ids='HP_0005268'>spontaneous abortions</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> associated with persistence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0005048'>Thrombosis</z:mp> may involve virtually <z:hpo ids='HP_0000001'>all</z:hpo> arterial or venous sites, but <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> of the lower limbs are the most common; however, unusual <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> that involve the portal vein have been described </plain></SENT>
<SENT sid="2" pm="."><plain>We report females with documented portal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> and primary APS </plain></SENT>
<SENT sid="3" pm="."><plain>The treatment of these patients is difficult because of the risk of <z:mp ids='MP_0001914'>bleeding</z:mp> and the <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> if they don't receive appropriate long-term <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
</text></document>